Intuitive Surgical Stock Price Target and Analyst Ratings (NASDAQ:ISRG)

Analyst Price Target for ISRG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$736.06

▼ -2.67% Downside Potential

This price target is based on 21 analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $736.06, with a high forecast of $879.00 and a low forecast of $410.00. The average price target represents a -2.67% upside from the last price of $756.28.

Hold

The current consensus among 21 contributing investment analysts is to hold stock in Intuitive Surgical. This rating has held steady since October 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
7 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

8/1/2019

0 strong buy ratings
8 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

10/30/2019

0 strong buy ratings
8 buy ratings
5 hold ratings
2 sell ratings

Ratings as of

1/28/2020

0 strong buy ratings
10 buy ratings
8 hold ratings
4 sell ratings

Ratings as of

4/27/2020

0 strong buy ratings
11 buy ratings
8 hold ratings
3 sell ratings

Ratings as of

7/26/2020

0 strong buy ratings
11 buy ratings
8 hold ratings
3 sell ratings

Ratings as of

10/24/2020

0 strong buy ratings
11 buy ratings
8 hold ratings
3 sell ratings

Ratings as of

12/23/2020

0 strong buy ratings
10 buy ratings
8 hold ratings
3 sell ratings

Ratings as of

1/22/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
1/22/2021	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$825.00 ➝ $840.00	Low	i
1/22/2021	Raymond James	Boost Price Target	Outperform	$800.00 ➝ $865.00	High	i
1/22/2021	Wells Fargo & Company	Boost Price Target	Overweight	$841.00 ➝ $879.00	High	i
1/22/2021	Oppenheimer	Boost Price Target	Underperform	$365.00 ➝ $410.00	High	i
1/22/2021	Piper Sandler	Boost Price Target	Neutral	$680.00 ➝ $730.00	High	i
12/15/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$780.00	Medium	i
10/16/2020	SVB Leerink	Boost Price Target	Market Perform	$690.00 ➝ $725.00	High	i
10/16/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$765.00 ➝ $785.00	High	i
10/16/2020	Stifel Nicolaus	Boost Price Target	Buy	$725.00 ➝ $815.00	High	i
10/16/2020	Wells Fargo & Company	Boost Price Target	Overweight	$727.00 ➝ $815.00	High	i
10/16/2020	Morgan Stanley	Boost Price Target	Overweight	$735.00 ➝ $785.00	High	i
10/16/2020	Piper Sandler	Boost Price Target	Neutral	$595.00 ➝ $680.00	High	i
10/15/2020	BTIG Research	Reiterated Rating	Hold		High	i
10/12/2020	Raymond James	Boost Price Target	Outperform	$725.00 ➝ $800.00	High	i
9/28/2020	Argus	Initiated Coverage	Buy	$775.00	Medium	i
9/14/2020	BTIG Research	Reiterated Rating	Hold		Low	i
9/11/2020	Wolfe Research	Initiated Coverage	Outperform	$789.00	Low	i
9/8/2020	Bank of America	Downgrade	Buy ➝ Neutral	$725.00 ➝ $760.00	High	i
9/1/2020	Robert W. Baird	Initiated Coverage	Neutral	$700.00	High	i
8/14/2020	SVB Leerink	Boost Price Target	Market Perform	$650.00 ➝ $690.00	Low	i Rating by Richard Newitter at SVB Leerink LLC
8/3/2020	BTIG Research	Reiterated Rating	Hold		Low	i
7/22/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$600.00 ➝ $700.00	High	i Rating by Tycho Peterson at JPMorgan Chase & Co.
7/22/2020	UBS Group	Boost Price Target	Neutral	$565.00 ➝ $670.00	Medium	i
7/22/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$500.00 ➝ $600.00	Medium	i
7/22/2020	Morgan Stanley	Boost Price Target	Overweight	$602.00 ➝ $735.00	Medium	i
7/22/2020	Canaccord Genuity	Boost Price Target	Buy	$562.00 ➝ $725.00	Medium	i
7/22/2020	SVB Leerink	Boost Price Target	Market Perform	$590.00 ➝ $650.00	Medium	i Rating by Richard Newitter at SVB Leerink LLC
7/22/2020	Raymond James	Boost Price Target	Outperform	$600.00 ➝ $725.00	Low	i
7/22/2020	Piper Sandler	Boost Price Target	Neutral	$510.00 ➝ $595.00	Medium	i Rating by Adam Maeder at Piper Sandler
7/22/2020	Wells Fargo & Company	Boost Price Target	Overweight	$632.00 ➝ $727.00	Medium	i
7/20/2020	Sanford C. Bernstein	Boost Price Target	Outperform	$625.00 ➝ $725.00	Medium	i Rating by Lee Hambright at Sanford C. Bernstein
7/20/2020	Stifel Nicolaus	Boost Price Target	Buy	$575.00 ➝ $715.00	Medium	i
7/15/2020	SVB Leerink	Boost Price Target	Market Perform	$535.00 ➝ $590.00	High	i Rating by Richard Newitter at SVB Leerink LLC
7/13/2020	Sanford C. Bernstein	Reiterated Rating	Buy	$625.00	High	i Rating by Lee Hambright at Sanford C. Bernstein
6/18/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$565.00 ➝ $600.00	Low	i Rating by Tycho Peterson at JPMorgan Chase & Co.
6/16/2020	OTR Global	Downgrade	Positive		Low	i
6/4/2020	Wells Fargo & Company	Boost Price Target	Overweight	$561.00 ➝ $632.00	Medium	i
4/28/2020	Oppenheimer	Reiterated Rating	Sell	$365.00	High	i Rating by Suraj Kalia at Oppenheimer Holdings Inc.
4/28/2020	Piper Sandler	Downgrade	Overweight ➝ Neutral	$570.00 ➝ $510.00	Medium	i Rating by Adam Maeder at Piper Sandler
4/19/2020	Evercore ISI	Downgrade	In-Line ➝ Underperform		Low	i
4/17/2020	UBS Group	Lower Price Target	Neutral	$620.00 ➝ $565.00	Medium	i
4/17/2020	Cfra	Downgrade	Hold ➝ Sell		Medium	i
4/17/2020	Piper Sandler	Lower Price Target		$633.00 ➝ $570.00	High	i Rating by Adam Maeder at Piper Sandler
4/17/2020	Wells Fargo & Company	Boost Price Target	Overweight	$555.00 ➝ $561.00	Medium	i Rating by Larry Biegelsen at Wells Fargo & Company
4/17/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$595.00 ➝ $500.00	Low	i
4/17/2020	Stifel Nicolaus	Boost Price Target	Buy	$425.00 ➝ $575.00	Low	i
4/17/2020	Canaccord Genuity	Lower Price Target	Accumulate ➝ Buy	$655.00 ➝ $562.00	Low	i Rating by Jason Mills at Canaccord Genuity
4/17/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$575.00 ➝ $535.00	Medium	i
4/17/2020	BTIG Research	Reiterated Rating	Hold		High	i
4/13/2020	Raymond James	Lower Price Target	Outperform	$660.00 ➝ $600.00	Low	i Rating by Lawrence Keusch at Raymond James
4/9/2020	Bank of America	Reiterated Rating	Buy	$650.00	Low	i
4/9/2020	Evercore ISI	Downgrade	In-Line ➝ Underperform		Low	i
4/8/2020	Piper Sandler	Reiterated Rating	Buy	$633.00	High	i Rating by Adam Maeder at Piper Sandler
4/2/2020	Wells Fargo & Company	Lower Price Target	Overweight	$655.00 ➝ $545.00	Medium	i Rating by Larry Biegelsen at Wells Fargo & Company
4/1/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium	i
4/1/2020	Oppenheimer	Downgrade	Market Perform ➝ Underperform	$365.00	High	i Rating by Suraj Kalia at Oppenheimer Holdings Inc.
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$670.00 ➝ $622.00	Low	i Rating by David Lewis at Morgan Stanley
3/24/2020	Stifel Nicolaus	Lower Price Target	Buy	$665.00 ➝ $425.00	High	i
3/17/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$665.00 ➝ $575.00	High	i Rating by Tycho Peterson at JPMorgan Chase & Co.
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$725.00	Medium	i
1/27/2020	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$610.00 ➝ $595.00	Low	i
1/24/2020	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$575.00 ➝ $665.00	High	i
1/24/2020	Raymond James	Boost Price Target	Outperform	$615.00 ➝ $660.00	High	i Rating by Lawrence Keusch at Raymond James
1/24/2020	Canaccord Genuity	Reiterated Rating	Buy		High	i Rating by Jason Mills at Canaccord Genuity
1/10/2020	Canaccord Genuity	Reiterated Rating	Buy	$655.00	Low	i Rating by Jason Mills at Canaccord Genuity
1/10/2020	UBS Group	Boost Price Target	Neutral	$590.00 ➝ $620.00	Medium	i Rating by Matthew Taylor at UBS Group AG
1/10/2020	Cantor Fitzgerald	Reiterated Rating	Overweight	$620.00 ➝ $690.00	Medium	i Rating by Craig Bijou at Cantor Fitzgerald
12/17/2019	Morgan Stanley	Boost Price Target	Overweight	$620.00 ➝ $670.00	Low	i Rating by David Lewis at Morgan Stanley
12/9/2019	Wells Fargo & Company	Reiterated Rating	Overweight	$620.00 ➝ $655.00	High	i Rating by Larry Biegelsen at Wells Fargo & Company
11/20/2019	Oppenheimer	Initiated Coverage	Market Perform		Low	i
10/18/2019	Piper Jaffray Companies	Set Price Target	Buy	$633.00	Low	i Rating by JP McKim at Piper Jaffray Companies
10/18/2019	Royal Bank of Canada	Set Price Target	Hold	$570.00	Low	i Rating by Brandon Henry at Royal Bank of Canada
10/18/2019	Morgan Stanley	Set Price Target	Buy	$620.00	Low	i Rating by David Lewis at Morgan Stanley
10/18/2019	Wells Fargo & Company	Set Price Target	Buy	$620.00	Low	i Rating by Larry Biegelsen at Wells Fargo & Company
10/18/2019	Raymond James	Boost Price Target	Buy	$610.00 ➝ $625.00	Low	i
10/18/2019	UBS Group	Boost Price Target	Neutral	$560.00 ➝ $590.00	High	i Rating by Matthew Taylor at UBS Group AG
9/13/2019	Redburn Partners	Initiated Coverage	Buy		Low	i
7/19/2019	Northland Securities	Set Price Target	Sell	$375.00	Low	i Rating by Suraj Kalia at Northland Securities
7/19/2019	Cantor Fitzgerald	Set Price Target	Buy	$620.00	Low	i Rating by Craig Bijou at Cantor Fitzgerald
7/19/2019	Morgan Stanley	Set Price Target	Buy	$620.00	Low	i Rating by David Lewis at Morgan Stanley
7/19/2019	UBS Group	Set Price Target	Hold	$560.00	Low	i Rating by Matthew Taylor at UBS Group AG
7/19/2019	Canaccord Genuity	Reiterated Rating	Buy ➝ Buy	$575.00 ➝ $610.00	Medium	i
7/19/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$610.00 ➝ $633.00	Medium	i
5/22/2019	Piper Jaffray Companies	Upgrade	Overweight	$610.00	Low	i
5/14/2019	Citigroup	Lower Price Target	Buy	$611.00 ➝ $575.00	Low	i
4/23/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$684.00 ➝ $611.00	Medium	i
4/22/2019	Raymond James	Lower Price Target	Outperform ➝ Outperform	$630.00 ➝ $610.00	High	i
4/22/2019	Canaccord Genuity	Reiterated Rating	Buy ➝ Buy	$610.00 ➝ $575.00	Low	i
4/21/2019	BTIG Research	Reiterated Rating	Hold		Low	i
4/18/2019	Piper Jaffray Companies	Reiterated Rating	Overweight	$610.00	Low	i
4/4/2019	Cantor Fitzgerald	Set Price Target	Buy	$620.00	Low	i Rating by Craig Bijou at Cantor Fitzgerald
4/1/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$630.00 ➝ $630.00	Low	i
4/1/2019	Raymond James	Boost Price Target	Outperform ➝ Outperform	$600.00 ➝ $630.00	Low	i
2/28/2019	Royal Bank of Canada	Set Price Target	Hold	$560.00	High	i Rating by Brandon Henry at Royal Bank of Canada
1/25/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$620.00	Low	i
1/25/2019	Stifel Nicolaus	Lower Price Target	Buy	$600.00 ➝ $570.00	Low	i
1/10/2019	Northland Securities	Reiterated Rating	Sell	$375.00	Low	i
1/2/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$601.00 ➝ $560.00	Low	i
11/29/2018	Citigroup	Lower Price Target	Buy ➝ Buy	$606.00 ➝ $601.00	Low	i
11/27/2018	UBS Group	Initiated Coverage	Neutral	$540.00	High	i
10/31/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$613.00 ➝ $625.00	Low	i
10/21/2018	BTIG Research	Reiterated Rating	Hold		Medium	i
10/19/2018	Royal Bank of Canada	Reiterated Rating	Hold	$560.00	High	i Rating by Brandon Henry at Royal Bank of Canada
10/19/2018	Raymond James	Boost Price Target	Outperform ➝ Outperform	$620.00 ➝ $630.00	High	i
10/19/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$613.00	High	i
10/19/2018	Canaccord Genuity	Upgrade	Hold ➝ Buy	$550.00 ➝ $610.00	High	i
10/19/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$620.00	High	i
10/11/2018	Morgan Stanley	Boost Price Target	Overweight	$575.00 ➝ $600.00	Low	i
10/9/2018	Piper Jaffray Companies	Upgrade	Neutral ➝ Overweight	$600.00	High	i
9/12/2018	Wells Fargo & Company	Boost Price Target	Outperform ➝ Outperform	$575.00 ➝ $635.00	Medium	i
8/2/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$561.00 ➝ $592.00	Low	i
7/22/2018	BTIG Research	Reiterated Rating	Hold		Low	i
7/20/2018	Northland Securities	Reiterated Rating	Sell	$300.00	Medium	i
7/20/2018	The Goldman Sachs Group	Boost Price Target	Buy	$540.00 ➝ $630.00	High	i
7/20/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$515.00 ➝ $600.00	High	i
7/20/2018	Morgan Stanley	Reiterated Rating	Overweight ➝ Overweight	$535.00 ➝ $575.00	High	i
7/20/2018	Royal Bank of Canada	Set Price Target	Hold	$550.00	High	i Rating by Brandon Henry at Royal Bank of Canada
7/20/2018	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$575.00	High	i
7/20/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$510.00 ➝ $620.00	High	i
7/17/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$510.00 ➝ $600.00	Low	i
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Outperform	$560.00	Medium	i
6/1/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$525.00 ➝ $535.00	High	i
4/18/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$465.00 ➝ $510.00	Low	i
4/18/2018	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$410.00 ➝ $430.00	High	i
4/18/2018	Royal Bank of Canada	Set Price Target	Hold	$460.00	High	i Rating by Brandon Henry at Royal Bank of Canada
4/18/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$500.00 ➝ $525.00	High	i
4/18/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$480.00 ➝ $515.00	High	i
4/18/2018	SVB Leerink	Reiterated Rating	Outperform	$475.00 ➝ $510.00	High	i
4/18/2018	Cantor Fitzgerald	Boost Price Target	Overweight	$510.00	High	i
4/18/2018	Piper Jaffray Companies	Boost Price Target	Neutral	$460.00	High	i
2/6/2018	Citigroup	Lower Price Target	Buy ➝ Buy	$507.00	Medium	i
1/26/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$450.00 ➝ $500.00	Low	i
1/26/2018	Royal Bank of Canada	Boost Price Target	Sector Perform	$430.00	High	i Rating by Brandon Henry at Royal Bank of Canada
1/26/2018	Canaccord Genuity	Reiterated Rating	Hold ➝ Hold	$380.00 ➝ $410.00	High	i
1/26/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$490.00	High	i
1/26/2018	Citigroup	Reiterated Rating	Buy	$531.00	High	i
1/26/2018	Barclays	Boost Price Target	Overweight ➝ Overweight	$475.00	High	i
1/26/2018	Piper Jaffray Companies	Reiterated Rating	Hold		High	i
1/25/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$400.00 ➝ $480.00	High	i
1/18/2018	SVB Leerink	Reiterated Rating	Outperform ➝ Outperform	$390.00 ➝ $475.00	Low	i
1/11/2018	Barclays	Reiterated Rating	Overweight ➝ Overweight	$465.00	Medium	i
1/5/2018	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$410.00	Low	i
1/3/2018	Evercore ISI	Initiated Coverage	In ➝ In-Line	$380.00	High	i
11/18/2017	The Goldman Sachs Group	Reiterated Rating	Buy		N/A	i Rating by Isaac Ro at The Goldman Sachs Group, Inc.
10/20/2017	Barclays	Reiterated Rating	Overweight		N/A	i
10/17/2017	Canaccord Genuity	Reiterated Rating	Hold		N/A	i
10/16/2017	Wells Fargo & Company	Reiterated Rating	Buy		N/A	i
10/10/2017	Wedbush	Reiterated Rating	Buy		N/A	i
9/25/2017	Wedbush	Reiterated Rating	Outperform	$353.33	Low	i
9/5/2017	Morgan Stanley	Reiterated Rating	Overweight		High	i Rating by Jonathan Demchick at Morgan Stanley
9/1/2017	Royal Bank of Canada	Reiterated Rating	Hold	$333.33	N/A	i
7/26/2017	Canaccord Genuity	Reiterated Rating	Hold	$290.01 ➝ $333.33	Low	i
7/25/2017	Morgan Stanley	Reiterated Rating	Overweight	$316.68 ➝ $356.67	Low	i Rating by Jonathan Demchick at Morgan Stanley
7/24/2017	Citigroup	Reiterated Rating	Buy	$305.67 ➝ $359.34	Low	i
7/22/2017	Stifel Nicolaus	Reiterated Rating	Buy	$283.32 ➝ $366.66	Medium	i
7/21/2017	Royal Bank of Canada	Reiterated Rating	Hold	$333.33	Medium	i
7/21/2017	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$350.01	High	i
7/21/2017	Barclays	Boost Price Target	Overweight	$290.01 ➝ $333.33	High	i
7/21/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$350.01	High	i
7/18/2017	Royal Bank of Canada	Boost Price Target	Sector Perform ➝ Sector Perform	$266.67 ➝ $316.68	Low	i
7/12/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$333.33 ➝ $350.01	Low	i
7/11/2017	Canaccord Genuity	Reiterated Rating	Hold	$290.01	Low	i
7/5/2017	SVB Leerink	Reiterated Rating	Outperform		Medium	i
6/29/2017	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$333.33	Low	i
6/15/2017	BTIG Research	Reiterated Rating	Hold		Low	i
6/1/2017	Bank of America	Reiterated Rating	Buy	$333.33	Low	i Rating by Bob Hopkins at Bank of America Co.
5/30/2017	Canaccord Genuity	Downgrade	Buy ➝ Hold	$290.01	Low	i
5/25/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$333.33	Low	i
5/22/2017	Morgan Stanley	Set Price Target	Overweight	$279.99 ➝ $316.68	Low	i
5/16/2017	The Goldman Sachs Group	Initiated Coverage	Buy ➝ Buy	$333.33	Medium	i
4/25/2017	Jefferies Financial Group	Reiterated Rating	Buy	$225.00	Low	i
4/24/2017	Wedbush	Boost Price Target	Outperform	$278.34 ➝ $291.66	Low	i
4/22/2017	SVB Leerink	Reiterated Rating	Outperform	$279.99 ➝ $283.32	Low	i
4/22/2017	Citigroup	Reiterated Rating	Buy	$273.33 ➝ $305.67	Low	i
4/20/2017	BTIG Research	Reiterated Rating	Hold		Low	i
4/19/2017	Stifel Nicolaus	Boost Price Target	Buy	$266.67 ➝ $283.32	Low	i
4/19/2017	Evercore ISI	Boost Price Target	In-Line	$249.99 ➝ $261.66	Low	i
4/19/2017	Canaccord Genuity	Reiterated Rating	Buy	$266.67 ➝ $290.01	Medium	i
4/19/2017	Wedbush	Boost Price Target	Outperform ➝ Outperform	$266.67 ➝ $278.34	High	i
4/19/2017	Barclays	Reiterated Rating	Buy	$266.67 ➝ $276.66	High	i
4/17/2017	Royal Bank of Canada	Boost Price Target	Sector Perform ➝ Sector Perform	$240.00 ➝ $256.68	Medium	i
3/26/2017	Barclays	Reiterated Rating	Buy	$266.67	Medium	i
3/24/2017	Canaccord Genuity	Reiterated Rating	Buy	$266.67	Low	i
2/14/2017	Bank of America	Set Price Target	Buy	$256.68 ➝ $266.67	N/A	i
1/25/2017	Canaccord Genuity	Reiterated Rating	Buy		N/A	i
1/14/2017	Wedbush	Reiterated Rating	Outperform	$266.67	N/A	i
1/4/2017	Evercore ISI	Downgrade	Buy ➝ Hold	$230.01	N/A	i
10/21/2016	Barclays	Reiterated Rating	Overweight	$249.99 ➝ $253.32	N/A	i Rating by Matthew Taylor at Barclays PLC
10/19/2016	Canaccord Genuity	Boost Price Target	Buy	$249.99 ➝ $266.67	N/A	i Rating by Jason Mills at Canaccord Genuity
10/19/2016	Wedbush	Reiterated Rating	Outperform	$261.66 ➝ $251.67	N/A	i
10/19/2016	Royal Bank of Canada	Set Price Target	Hold	$249.99 ➝ $253.32	N/A	i
10/19/2016	Royal Bank of Canada	Boost Price Target	Sector Perform	$250.00 ➝ $253.32	N/A	i
10/13/2016	Wells Fargo & Company	Initiated Coverage	Outperform		N/A	i
9/20/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A	i Rating by Tycho Peterson at JPMorgan Chase & Co.
9/20/2016	BTIG Research	Reiterated Rating	Hold		N/A	i Rating by Sean Lavin at BTIG Research
9/19/2016	SVB Leerink	Reiterated Rating	Outperform	$260.01	N/A	i
8/26/2016	Raymond James	Initiated Coverage	Outperform		N/A	i
7/21/2016	Northland Securities	Downgrade		$200.00	N/A	i
7/20/2016	Evercore ISI	Reiterated Rating	Buy	$250.00 ➝ $258.33	N/A	i Rating by Vijay Kumar at Evercore ISI
7/20/2016	Citigroup	Boost Price Target	Buy	$241.00 ➝ $259.68	N/A	i Rating by Amit Hazan at Citigroup Inc.
7/20/2016	Barclays	Boost Price Target	Overweight	$230.00 ➝ $250.00	N/A	i Rating by Matthew Taylor at Barclays PLC
7/20/2016	Piper Jaffray Companies	Reiterated Rating	Neutral	$203.34 ➝ $233.34	N/A	i Rating by Matthew O'Brien at Piper Jaffray Companies
7/20/2016	BTIG Research	Reiterated Rating	Neutral		N/A	i Rating by Sean Lavin at BTIG Research
7/20/2016	Canaccord Genuity	Boost Price Target	Buy	$233.34 ➝ $250.00	N/A	i Rating by Jason Mills at Canaccord Genuity
7/20/2016	Wedbush	Boost Price Target	Outperform	$238.32 ➝ $251.67	N/A	i
7/20/2016	Stifel Nicolaus	Boost Price Target	Buy	$233.34 ➝ $266.67	N/A	i
6/22/2016	Bank of America	Reiterated Rating	Buy		N/A	i Rating by Bob Hopkins at Bank of America Co.
6/18/2016	Barclays	Reiterated Rating	Buy		N/A	i Rating by Matthew Taylor at Barclays PLC
6/15/2016	Piper Jaffray Companies	Reiterated Rating	Neutral	$203.34	N/A	i Rating by Matthew O'Brien at Piper Jaffray Companies
6/7/2016	Canaccord Genuity	Reiterated Rating	Buy	$233.34	N/A	i Rating by Jason Mills at Canaccord Genuity
6/6/2016	Bank of America	Reiterated Rating	Buy		N/A	i Rating by Bob Hopkins at Bank of America Co.
6/2/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A	i Rating by Tycho Peterson at JPMorgan Chase & Co.
6/2/2016	Citigroup	Reiterated Rating	Buy		N/A	i Rating by Amit Hazan at Citigroup Inc.
6/2/2016	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$211.00 ➝ $224.67	N/A	i
4/20/2016	SVB Leerink	Boost Price Target	Outperform	$233.34 ➝ $236.67	N/A	i Rating by Richard Newitter at SVB Leerink LLC
4/20/2016	Piper Jaffray Companies	Boost Price Target	Neutral	$183.33 ➝ $203.34	N/A	i Rating by Matthew O'Brien at Piper Jaffray Companies
4/20/2016	Morgan Stanley	Reiterated Rating	Buy		N/A	i Rating by David Lewis at Morgan Stanley
4/20/2016	Bank of America	Reiterated Rating	Buy	$213.33 ➝ $250.00	N/A	i
4/20/2016	Evercore ISI	Boost Price Target	Buy	$225.00 ➝ $233.34	N/A	i Rating by Vijay Kumar at Evercore ISI
4/20/2016	Stifel Nicolaus	Boost Price Target	Buy	$213.33 ➝ $233.34	N/A	i
4/20/2016	Wedbush	Reiterated Rating	Outperform	$226.68	N/A	i
4/20/2016	Canaccord Genuity	Reiterated Rating	Buy	$221.34 ➝ $233.34	N/A	i Rating by Jason Mills at Canaccord Genuity
4/20/2016	Royal Bank of Canada	Boost Price Target	Sector Perform	$203.34 ➝ $213.33	N/A	i
4/14/2016	Sterne Agee CRT	Reiterated Rating	Neutral		N/A	i
4/12/2016	SVB Leerink	Boost Price Target	Outperform	$213.33 ➝ $233.34	N/A	i Rating by Richard Newitter at SVB Leerink LLC
4/8/2016	The Goldman Sachs Group	Boost Price Target		$211.00 ➝ $221.34	N/A	i
4/1/2016	BTIG Research	Downgrade	Buy ➝ Neutral	$200.00	N/A	i
3/31/2016	Piper Jaffray Companies	Reiterated Rating	Hold	$183.33	N/A	i Rating by Matthew O'Brien at Piper Jaffray Companies
3/25/2016	Bank of America	Reiterated Rating	Buy	$213.33	N/A	i
3/17/2016	Canaccord Genuity	Initiated Coverage	Buy	$221.34	N/A	i Rating by Jason Mills at Canaccord Genuity
3/14/2016	Bank of America	Reiterated Rating	Buy	$213.33	N/A	i
2/29/2016	Canaccord Genuity	Reiterated Rating	Buy		N/A	i Rating by Jason Mills at Canaccord Genuity
1/25/2016	Barclays	Reiterated Rating	Overweight	$216.67	N/A	i
1/24/2016	Piper Jaffray Companies	Reiterated Rating	Hold		N/A	i Rating by Matthew O'Brien at Piper Jaffray Companies
1/22/2016	SVB Leerink	Reiterated Rating	Buy		N/A	i Rating by Richard Newitter at SVB Leerink LLC
1/22/2016	BTIG Research	Reiterated Rating	Buy	$191.67 ➝ $200.00	N/A	i
1/22/2016	Wedbush	Reiterated Rating	Outperform	$226.67	N/A	i Rating by Tao Levy at Wedbush
1/22/2016	Evercore ISI	Reiterated Rating	Buy	$200.00 ➝ $206.67	N/A	i Rating by Vijay Kumar at Evercore ISI
1/22/2016	Canaccord Genuity	Reiterated Rating	Buy	$208.32	N/A	i Rating by Jason Mills at Canaccord Genuity
1/22/2016	William Blair	Reiterated Rating	Buy		N/A	i
1/22/2016	Stifel Nicolaus	Boost Price Target	Buy	$200.00 ➝ $213.33	N/A	i

(Data available from 1/22/2016 forward)

Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; and EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.

Today's Range

Now: $756.28

$748.59

$795.58

50 Day Range

MA: $791.88

$753.51

$818.75

52 Week Range

Now: $756.28

$360.50

$826.81

Volume

74,100 shs

Average Volume

598,710 shs

Market Capitalization

$88.90 billion

P/E Ratio

86.14

Dividend Yield

N/A

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?

The following Wall Street research analysts have issued research reports on Intuitive Surgical in the last year: Argus, Bank of America Co., BTIG Research, Canaccord Genuity, Cfra, Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., OTR Global, Piper Sandler, Raymond James, Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.

What is the current price target for Intuitive Surgical?

17 Wall Street analysts have set twelve-month price targets for Intuitive Surgical in the last year. Their average twelve-month price target is $732.82, suggesting a possible downside of 5.9%. Wells Fargo & Company has the highest price target set, predicting ISRG will reach $879.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $410.00 for Intuitive Surgical in the next year.

What is the current consensus analyst rating for Intuitive Surgical?

Intuitive Surgical currently has 3 sell ratings, 8 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ISRG, but not buy more shares or sell existing shares.

What other companies compete with Intuitive Surgical?

Other companies that are similar to Intuitive Surgical include Abbott Laboratories, Medtronic, Stryker, Becton, Dickinson and, Edwards Lifesciences, Boston Scientific, IDEXX Laboratories, Baxter International, DexCom, ResMed, Hologic, Insulet, Teleflex, STERIS and Varian Medical Systems.

How do I contact Intuitive Surgical's investor relations team?

Intuitive Surgical's physical mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider's listed phone number is 408-523-2100 and its investor relations email address is [email protected] The official website for Intuitive Surgical is www.intuitive.com.

NASDAQ:ISRG - Intuitive Surgical Stock Price Target and Predictions

Analyst Price Target for ISRG

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?

What is the current price target for Intuitive Surgical?

What is the current consensus analyst rating for Intuitive Surgical?

What other companies compete with Intuitive Surgical?

How do I contact Intuitive Surgical's investor relations team?